309 related articles for article (PubMed ID: 34130705)
1. TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner.
Miao C; Liang C; Li P; Liu B; Qin C; Yuan H; Liu Y; Zhu J; Cui Y; Xu A; Wang S; Su S; Li J; Shao P; Wang Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):195. PubMed ID: 34130705
[TBL] [Abstract][Full Text] [Related]
2. TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein.
Bhatnagar S; Gazin C; Chamberlain L; Ou J; Zhu X; Tushir JS; Virbasius CM; Lin L; Zhu LJ; Wajapeyee N; Green MR
Nature; 2014 Dec; 516(7529):116-20. PubMed ID: 25470042
[TBL] [Abstract][Full Text] [Related]
3. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling.
Zheng D; Ning J; Deng H; Ruan Y; Cheng F
J Transl Med; 2024 May; 22(1):481. PubMed ID: 38773612
[TBL] [Abstract][Full Text] [Related]
4. TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3.
Zhang Q; Li Y; Zhu Q; Xie T; Xiao Y; Zhang F; Li N; Deng K; Xin H; Huang X
Cell Death Dis; 2024 May; 15(5):355. PubMed ID: 38777825
[TBL] [Abstract][Full Text] [Related]
5. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
[TBL] [Abstract][Full Text] [Related]
6. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37.
Ge Y; Zhao R; Li B; Xiao B; Zhou L; Zuo S
Exp Cell Res; 2022 Dec; 421(2):113377. PubMed ID: 36252649
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Assay to Study Histone Ubiquitination During Transcriptional Regulation.
Tushir-Singh J; Bhatnagar S
Methods Mol Biol; 2017; 1507():235-244. PubMed ID: 27832544
[TBL] [Abstract][Full Text] [Related]
8. TRIM37 negatively regulates inflammatory responses induced by virus infection via controlling TRAF6 ubiquitination.
Zhao L; Hao Y; Song Z; Fan Y; Li S
Biochem Biophys Res Commun; 2021 Jun; 556():87-92. PubMed ID: 33839419
[TBL] [Abstract][Full Text] [Related]
9. Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.
Fukasawa H; Yamamoto T; Fujigaki Y; Misaki T; Ohashi N; Takayama T; Suzuki S; Mugiya S; Oda T; Uchida C; Kitagawa K; Hattori T; Hayashi H; Ozono S; Kitagawa M; Hishida A
Int J Cancer; 2010 Oct; 127(7):1517-25. PubMed ID: 20073064
[TBL] [Abstract][Full Text] [Related]
10. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway.
Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T
J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491
[TBL] [Abstract][Full Text] [Related]
11. TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression.
Cui G; Gao Z; Chang S; Narwade N; Chen Y; Poudel B; Lei KMK; Zhang W; Li G; Poon TCW; Cheung E
Int J Biol Sci; 2022; 18(11):4316-4328. PubMed ID: 35864973
[TBL] [Abstract][Full Text] [Related]
12. TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.
Yamada Y; Kimura N; Takayama KI; Sato Y; Suzuki T; Azuma K; Fujimura T; Ikeda K; Kume H; Inoue S
Cancer Sci; 2020 Mar; 111(3):881-890. PubMed ID: 31883420
[TBL] [Abstract][Full Text] [Related]
13. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
[TBL] [Abstract][Full Text] [Related]
14. RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
Yu S; Dai J; Ma M; Xu T; Kong Y; Cui C; Chi Z; Si L; Tang H; Yang L; Sheng X; Guo J
Cell Death Dis; 2019 Mar; 10(4):254. PubMed ID: 30874541
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma.
Wu L; Yin X; Jiang K; Yin J; Yu H; Yang L; Ma C; Yan S
Cancer Med; 2022 Apr; 11(7):1712-1731. PubMed ID: 35142083
[TBL] [Abstract][Full Text] [Related]
16. TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.
Meitinger F; Ohta M; Lee KY; Watanabe S; Davis RL; Anzola JV; Kabeche R; Jenkins DA; Shiau AK; Desai A; Oegema K
Nature; 2020 Sep; 585(7825):440-446. PubMed ID: 32908304
[TBL] [Abstract][Full Text] [Related]
17. TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase.
Kallijärvi J; Lahtinen U; Hämäläinen R; Lipsanen-Nyman M; Palvimo JJ; Lehesjoki AE
Exp Cell Res; 2005 Aug; 308(1):146-55. PubMed ID: 15885686
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits the proliferation and invasion of ovarian cancer cells by suppressing tripartite motif-containing 37-induced tumor necrosis factor receptor-associated factor 2 ubiquitination.
Zheng Y; Zhang H; Sun H
Cancer Sci; 2022 Nov; 113(11):3776-3786. PubMed ID: 35950370
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer.
Przanowski P; Lou S; Tihagam RD; Mondal T; Conlan C; Shivange G; Saltani I; Singh C; Xing K; Morris BB; Mayo MW; Teixeira L; Lehmann-Che J; Tushir-Singh J; Bhatnagar S
Cancer Res; 2020 Nov; 80(21):4791-4804. PubMed ID: 32855208
[TBL] [Abstract][Full Text] [Related]
20. lncRNA NUTM2A-AS1 Targets the SRSF1/Trim37 Signaling Pathway to Promote the Proliferation and Invasion of Breast Cancer.
Ning X; Zhao J; He F; Yuan Y; Li B; Ruan J
Comput Math Methods Med; 2022; 2022():3299336. PubMed ID: 35959349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
